These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 17542745)
21. [Method for the simultaneous immunization against influenza using inactivated and live vaccines]. Orlov VA; Ermolaeva OM; Malikova EV; Zakharina VN; Konstantinov VK Tr Inst Im Pastera; 1982; 59():62-4. PubMed ID: 7187569 [No Abstract] [Full Text] [Related]
22. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age. Vesikari T; Karvonen A; Smith HM; Dunning A; Razmpour A; Saville MK; Gruber WC; Forrest BD Pediatrics; 2008 Mar; 121(3):e568-73. PubMed ID: 18299305 [TBL] [Abstract][Full Text] [Related]
23. Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate. Wressnigg N; Voss D; Wolff T; Romanova J; Ruthsatz T; Mayerhofer I; Reiter M; Nakowitsch S; Humer J; Morokutti A; Muster T; Egorov A; Kittel C Vaccine; 2009 May; 27(21):2851-7. PubMed ID: 19366569 [TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age. Belshe RB; Ambrose CS; Yi T Vaccine; 2008 Sep; 26 Suppl 4():D10-6. PubMed ID: 18611422 [TBL] [Abstract][Full Text] [Related]
25. Pandemic H5N1 influenza vaccine development: an update. El Sahly HM; Keitel WA Expert Rev Vaccines; 2008 Mar; 7(2):241-7. PubMed ID: 18324892 [TBL] [Abstract][Full Text] [Related]
26. Intranasal influenza vaccine: adding to the armamentarium for influenza control. Poland GA; Couch R JAMA; 1999 Jul; 282(2):182-4. PubMed ID: 10411201 [No Abstract] [Full Text] [Related]
27. Update on influenza A (H1N1) 2009 monovalent vaccines. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398 [TBL] [Abstract][Full Text] [Related]
28. Trial of nasal influenza vaccine expands. Veggeberg S Mol Med Today; 1997 Nov; 3(11):468. PubMed ID: 9430778 [No Abstract] [Full Text] [Related]
29. Vaccine decisions loom for new flu strain. Butler D Nature; 2009 May; 459(7244):144-5. PubMed ID: 19444174 [No Abstract] [Full Text] [Related]
30. [The immunizing efficacy of anti-influenza vaccines]. Profeta ML Nuovi Ann Ig Microbiol; 1982; 33(4-6):785-97. PubMed ID: 7187501 [No Abstract] [Full Text] [Related]
31. Getting shot: fac ts about the flu vaccine. Johns Hopkins Med Lett Health After 50; 2005 Dec; 17(10):6. PubMed ID: 16435427 [No Abstract] [Full Text] [Related]
32. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Tam JS; Capeding MR; Lum LC; Chotpitayasunondh T; Jiang Z; Huang LM; Lee BW; Qian Y; Samakoses R; Lolekha S; Rajamohanan KP; Narayanan SN; Kirubakaran C; Rappaport R; Razmpour A; Gruber WC; Forrest BD; Pediatr Infect Dis J; 2007 Jul; 26(7):619-28. PubMed ID: 17596805 [TBL] [Abstract][Full Text] [Related]
34. Influenza virus vaccine live intranasal--Aviron. Flumist, influenza vaccine live intranasal. Drugs R D; 2002; 3(2):123-9. PubMed ID: 12001816 [No Abstract] [Full Text] [Related]
35. [Anosmia after administration of influenza vaccine]. Fiser Dj; Borotski L Med Pregl; 1979; 32(9-10):455-7. PubMed ID: 530224 [No Abstract] [Full Text] [Related]
36. Policy statement--recommendations for the prevention and treatment of influenza in children, 2009 -2010. Committee on Infectious Diseases Pediatrics; 2009 Oct; 124(4):1216-26. PubMed ID: 19736264 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials. Rhorer J; Ambrose CS; Dickinson S; Hamilton H; Oleka NA; Malinoski FJ; Wittes J Vaccine; 2009 Feb; 27(7):1101-10. PubMed ID: 19095024 [TBL] [Abstract][Full Text] [Related]
38. Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines. Stech J Expert Rev Vaccines; 2008 Aug; 7(6):739-43. PubMed ID: 18665773 [TBL] [Abstract][Full Text] [Related]
39. A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. Cox RJ; Madhun AS; Hauge S; Sjursen H; Major D; Kuhne M; Höschler K; Saville M; Vogel FR; Barclay W; Donatelli I; Zambon M; Wood J; Haaheim LR Vaccine; 2009 Mar; 27(13):1889-97. PubMed ID: 19368768 [TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States. Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]